422 The mode of action of CYC202 (R-roscovitine) a cyclin dependent kinase inhibitor currently in phase II clinical trials
| Autor: | Green, S., MacCallum, D.E., Fleming, I.N., Melville, J., Watson, M., Frame, S., Watt, K., Anderson, S., Gianella-Borradori, A., Lane, D.P. |
|---|---|
| Zdroj: | In EJC Supplements 2004 2(8):126-126 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect